Abiant, Inc. Welcomes Dr. Masanori Ichise as Advisor, PET Data Modeling and
Deerfield, ILLINOIS - - April 4, 2008 - - Abiant, Inc., welcomes Dr. Masanori Ichise in the role of
Advisor, PET Data Modeling and Analysis.
Dr. Ichise is Medical Director of the Morton A. Kreitchman PET Center, Professor of Clinical Radiology
at Columbia University College of Physicians and Surgeons, and Co-director of the Division of
Nuclear Medicine. An internationally recognized researcher in PET and SPECT imaging of patients
with neuropsychiatric disorders such as Alzheimer’s and Parkinson’s diseases, he is well known for
his expertise in the quantification of imaging results. He has authored numerous articles and
pioneered multiple techniques for PET/SPECT analysis of brain chemistry. Before coming to
Columbia, he was Director of the Brain Molecular Imaging Program at Brigham and Women’s
Hospital in Boston and conducted research at Harvard Medical School. Previously, he was a
molecular imaging principal investigator at the NIH.
In his role with Abiant, Dr. Ichise is providing expertise and guidance regarding the selection and
implementation of kinetic models for a variety of PET radiotracers.
Dawn Matthews, CEO of Abiant, said "Dr. Ichise brings extensive knowledge and experience that
further increases our ability to provide high quality, insightful results to our customers regarding the
action of their compounds in the brain. His expertise and team approach have already been of great
value in our work."
Abiant, Inc. uses proprietary image analysis methods and software to provide a sensitive biomarker
of drug effects and disease progression. The imaging information, which includes biochemical,
functional, and structural measurements, can be used to accelerate or reduce risk of decision
making in both drug development and disease treatment. The Company’s focus areas include the
central nervous system, oncology, and inflammation. Further information can be found at www.
Forward Looking Statements
This press release may contain "forward-looking" statements identified by words such as “will,”
"achieve," and "enable." There are a number of important factors that could cause Abiant's results to
differ materially from those indicated by these forward-looking statements.
|Copyright 2006-2010 Abiant, Inc.
|Abiant, Inc. 480 West Center Street, Suite 202, Grayslake, Illinois 60030